Evidence map›Paper›PMID 36377913›Full record

ArticlemSphere2022

SARS-CoV-2 Genomic Diversity in Households Highlights the Challenges of Sequence-Based Transmission Inference.

Emily E Bendall, Gabriela Paz-Bailey, Gilberto A Santiago, Christina A Porucznik, Joseph B Stanford, Melissa S Stockwell, Jazmin Duque, Zuha Jeddy, Vic Veguilla, Chelsea Major and 4 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Inferring Viral Transmission Pathways from Within-Host Variation.medRxiv : the preprint server for health sciences · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Emily E BendallDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Gabriela Paz-BaileyCenters for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Gilberto A SantiagoCenters for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Christina A PorucznikDivision of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0003-1973-2917
Joseph B StanfordDivision of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0002-9932-3947
Melissa S StockwellDivision of Child and Adolescent Health, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Jazmin DuqueAbt Associates, Rockville, Maryland, USA.ORCID 0000-0003-3484-276X
Zuha JeddyAbt Associates, Rockville, Maryland, USA.
Vic VeguillaCenters for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Chelsea MajorCenters for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Vanessa Rivera-AmillPonce Research Institute, Ponce Health Sciences University, Ponce, Puerto Rico, USA.
Melissa A RolfesCenters for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Fatimah S DawoodCenters for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Adam S LauringDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0003-2906-8335
Centers for Disease Control and Prevention · USAbt Global (United States) · USUniversity of Michigan · USUniversity of Utah · USColumbia University · USPonce Health Sciences University · PR

Funding

Evolution and Transmission of Influenza Virus in Natural Human InfectionR01AI148371 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAURING, ADAM, MARTIN, EMILY TOTH · 2020 to 2024
$3.6M
NCEZID CDC HHS U01 CK000580NIAID NIH HHS R01 AI148371
6 · The paper itself

Abstract

The reliability of sequence-based inference of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission is not clear. Sequence data from infections among household members can define the expected genomic diversity of a virus along a defined transmission chain. SARS-CoV-2 cases were identified prospectively among 2,369 participants in 706 households. Specimens with a reverse transcription-PCR cycle threshold of ≤30 underwent whole-genome sequencing. Intrahost single-nucleotide variants (iSNV) were identified at a ≥5% frequency. Phylogenetic trees were used to evaluate the relationship of household and community sequences. There were 178 SARS-CoV-2 cases in 706 households. Among 147 specimens sequenced, 106 yielded a whole-genome consensus with coverage suitable for identifying iSNV. Twenty-six households had sequences from multiple cases within 14 days. Consensus sequences were indistinguishable among cases in 15 households, while 11 had ≥1 consensus sequence that differed by 1 to 2 mutations. Sequences from households and the community were often interspersed on phylogenetic trees. Identification of iSNV improved inference in 2 of 15 households with indistinguishable consensus sequences and in 6 of 11 with distinct ones. In multiple-infection households, whole-genome consensus sequences differed by 0 to 1 mutations. Identification of shared iSNV occasionally resolved linkage, but the low genomic diversity of SARS-CoV-2 limits the utility of "sequence-only" transmission inference.

Indexed as

COVID-19SARS-CoV-2Genome, ViralGenomicsHumansPhylogenyReproducibility of Resultsgenomic epidemiologyhouseholdSARS-CoV-2transmission

Identifiers

PMID36377913
PMCPMC9769559
OpenAlexW4309097397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.